The use of traditional and herbal medicine is practiced in the prevention, diagnosis, and treatment of diseases, and maintenance of health, and numerous studies have reported the benefits of traditional herb medicines [@bib1; @bib2; @bib3; @bib4; @bib5]. Despite the worldwide use of traditional medicine, there have been concerns about the lack of safety information. An important role of safety is to identify the poison that induces the adverse effects involved in the interaction between toxicants and the cells. The target organs that are affected may vary depending on the chemical properties of the toxicants and the cells [@bib6]. Hence, evaluation of safety studies helps us decide whether or not a new herbal medicine should be adopted for clinical use. Therefore, an acute oral safety study is vitally needed not only to identify the range of doses that could be used subsequently, but also to reveal the possible clinical signs elicited by the substances under investigation.

Ginseng (*Panax ginseng* Meyer) is a widely used traditional herb medicine [@bib7; @bib8; @bib9; @bib10]. There are several types of ginseng depending on the processing methods, including fresh ginseng, white ginseng, and red ginseng. Red ginseng is a type of steamed and dried ginseng that shows enhanced pharmacological effects compared with nonsteamed ginseng [@bib11; @bib12; @bib13; @bib14]. However, these diverse beneficial effects of red ginseng have been reported mainly with its water-soluble fractions, probably because red ginseng is widely consumed in the form of hot-water extract or its concentrates. The biological effects of the lipid soluble moiety of red ginseng have been little studied. We have recently demonstrated various biological activities and the underlying molecular mechanisms of red ginseng oil that was prepared by a supercritical CO~2~ extraction of marc generated after hot water extraction of red ginseng [@bib15; @bib16]. Red ginseng marc oil (RMO) has been shown to have potent antioxidant, hepatoprotective, and anti-inflammatory effects in cells and mice. Recently, several studies have demonstrated the nontoxic effects of ginseng in animals and human studies [@bib17; @bib18; @bib19; @bib20]. Lee et al [@bib21] reported that black ginseng produced by heat processing is nontoxic in an acute oral toxicity study. However, little is known about the safety and/or toxicity of red ginseng oil.

In this study, a single oral dose safety on RMO in Sprague--Dawley (SD) rats was conducted as the first step of safety evaluation, which will provide preliminary safety information regarding red ginseng oil.

Five-wk-old male and female SD rats from Hyochang Science (Daegu, South Korea) were used after a 1-wk acclimation to the laboratory environment. The experiment was performed in the animal laboratory under the following conditions: temperature 25 ± 2°C, relative humidity 50 ± 5%, and 12-h light/dark cycle. Drinking water and food were provided *ad libitum* throughout the experiment. All procedures were approved by the Animal Care and Used Committee of Inje University, Gimhae, South Korea. The animals were divided into four groups of five rats each upon receipt. As no toxicological data were available regarding the safety of red ginseng oil, the highest dosage level was selected as 5,000 mg/kg according to the recommendations of the Korea Food and Drug Administration Guidelines and the Organization for Economic Co-Operation and Development (OECD) Guidelines [@bib22; @bib23]. Both male and female rats were orally administered once at a dose of 5,000 mg/kg of RMO. In general, a nontoxic compound is recommended to be tested up to 2,000 mg/kg or 5,000 mg/kg for acute toxicity. Red ginseng is used as functional food and 5,000 mg/kg is deemed to be a better choice for the current study rather than 2,000 mg/kg, which is recommended as a maximum dose for drugs. Based on many previous reports, the oral route administration is probably the most convenient and commonly used one when studying single oral dose safety [@bib24; @bib25; @bib26].

In the present study, general symptoms, clinical signs, and mortality rates were examined at the given RMO dose and then daily for 14 d after the treatment. The clinical symptom is one of the major important observations to indicate the side effects on organs in the treated groups [@bib27]. All groups treated with RMO did not show any symptoms or abnormal clinical sings, and no deaths were observed during the study period ([Table 1](#tbl1){ref-type="table"}), indicating that the administration of the RMO has a negligible level of toxicity on the growth of the animals. In addition, no deaths or adverse clinical signs were observed due to gavage of RMO at a dose of 5,000 mg/kg ([Tables 2](#tbl2){ref-type="table"} and [3](#tbl3){ref-type="table"}). Also, food intake and water consumption were not affected by the administration of RMO (data not shown); moreover, it did not induce appetite suppression and had no deleterious effects, indicating that there was no disturbance in carbohydrate, protein, or fat metabolism.

Body weights were measured on the day of dosing (Day 0) prior to treatment, 1 d, 2 d, 7 d, 13 d, and 14 d after dosing. Typically, changes in body weight are one of the indicators of adverse effects of testing substances, and it is considered significant when body weight loss is more than 10% from the initial weight [@bib28]. In this study, the body weight data indicated that there were no statistically significant differences between RMO-treated groups and the control groups throughout the experimental period ([Fig. 1](#fig1){ref-type="fig"}). Furthermore, any decrease in body weight gain was not found in the male and female rats treated with RMO. The above results for single oral dose safety test suggest that RMO is safe and nontoxic to rats at the dose of 5,000 mg/kg.

All animals survived during the experiment and were subjected to terminal necropsy at the end of the experiment on Day 14. Necropsy is a key procedure of most safety and/or toxicity studies, and remarkable changes in tissues and organs are recorded during this process [@bib29]. No remarkable abnormalities were observed in animal organs including the naked eyes, liver, kidneys, lung, heart, thymus, spleen, adrenal glands, and reproductive organs ([Table 4](#tbl4){ref-type="table"}). Therefore, we concluded that the lethality of RMO after a single oral administration could be higher than 5,000 mg/kg in both male and female rats under current experimental conditions. According to the study of Jothy et al [@bib27], substances with LD~50~ values higher than 5,000 mg/kg by oral route are regarded as safe or practically nontoxic [@bib27]. Similar results were found for a single oral dose of *Coriolus versicolor* water extract (5,000 mg/kg) that was shown to be nontoxic to the tested SD rats [@bib30]. Meanwhile, a study performed by Fujii et al [@bib31], in which Oligonol was used, revealed that the extract did not cause any mortality up to 2,000 mg/kg and was thus considered safe [@bib31]. However, acute safety studies are hampered by limitations in detecting test substance-related effects on vital functions of cardiovascular, central nervous, and respiratory systems, which should be evaluated prior to human exposure [@bib32]. Further studies should be conducted to clarify the systemic safety of RMO using repeated-dose safety pharmacology studies.

The enzymatic activities of serum aspartate aminotransferase (AST) and alanine aminotransferase (ALT) were used as biochemical markers for hepatotoxicity. Blood samples from rats were centrifuged at 3,000 × *g* at 4°C for 10 min, and the AST and ALT activities in serum supernatants were determined using a commercially available kit (Youndong Pharm, Yong-In, South Korea). Hepatocellular damage is characterized by a mutual rise in serum levels of AST and ALT [@bib33]. Liver is the main target organ of acute toxicity in exposure to foreign substances being absorbed in intestines and metabolized to other compounds that may or may not be hepatotoxic to the mice [@bib34]. There were no significant changes in the serum levels of AST and ALT after RMO administration, demonstrating that liver function was preserved in male and female rats exposed to RMO for 14 d ([Fig. 2](#fig2){ref-type="fig"}). Moreover, lipid peroxidation was slightly decreased by the treatment of RMO (5,000 mg/kg), but not significantly. These data do not exhibit significant differences compared with the control group. Our results demonstrate that RMO caused no hepatotoxic effects in male and female rats up to 5,000 mg/kg acutely.

The present results show that RMO does not induce any apparent *in vivo* damage in the current single oral dose safety study. No death or signs of damage were observed in rats treated with RMO at a dose of 5,000 mg/kg, thus establishing its safety in use. A detailed experimental analysis of its chronic toxicity is essential for further support of RMO.
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![Body weight changes of rats exposed to a single-dose toxicity of red ginseng marc oil (RMO). (A) Male and (B) female Sprague--Dawley rats were administered orally with RMO at doses of 5,000 mg/kg (■) on the day after dosing. Control animals received the same amount of vehicle alone (♦). Data are presented as mean ± SD (*n* = 5). There was no significant difference in body weight between RMO-treated group and control group (*p* \> 0.05). RMO, red ginseng marc oil; SD, standard deviation.](gr1){#fig1}

![Hepatic parameters of rats exposed to a single-dose toxicity of red ginseng marc oil (RMO). Male and female Sprague--Dawley rats were administered orally with RMO (5,000 mg/kg), and hepatotoxicity parameters including serum aspartate aminotransferase (AST), alanine aminotransferase (ALT), and hepatic thiobarbituric acid reactive substances (TBARS) values were determined at the end of the experiment on Day 14. Data are presented as mean ± SD (*n* = 5). There was no significant difference in the hepatic parameters between RMO-treated group and control group (*p* \> 0.05). SD, standard deviation.](gr2){#fig2}

###### 

Mortality of Spraguee-Dawley (SD) rats orally treated with red ginseng marc oil (RMO) in a single-dose safety

  Sex         Group/Dose (mg/kg)   No. of animals   Days after dosing   Mortality, % (dead/total)                                                             
  ----------- -------------------- ---------------- ------------------- --------------------------- --- --- --- --- --- --- --- --- --- --- --- --- --------- ---------
  Male        RMO 0                5                0                   0                           0   0   0   0   0   0   0   0   0   0   0   0   0         0 (0/5)
  RMO 5,000   5                    0                0                   0                           0   0   0   0   0   0   0   0   0   0   0   0   0 (0/5)   
  Female      RMO 0                5                0                   0                           0   0   0   0   0   0   0   0   0   0   0   0   0         0 (0/5)
  RMO 5,000   5                    0                0                   0                           0   0   0   0   0   0   0   0   0   0   0   0   0 (0/5)   

###### 

Summary of clinical signs 1 in rats exposed to red ginseng marc oil (RMO)

  Sex                       Group/Dose (mg/kg)   No. of animals   Clinical signs   Hours (Day 0) after dosing               
  ------------------------- -------------------- ---------------- ---------------- ---------------------------- --- --- --- ---
  Male                      RMO 0                5                NOA              5                            5   5   5   5
  RMO 5,000                 5                    NOA              5                5                            2   2   2   
  Soft stool                0                    0                2                2                            2           
  Compound-colored stool    0                    0                1                1                            1           
  Female                    RMO 0                5                NOA              5                            5   5   5   5
  RMO 5,000                 5                    NOA              5                4                            4   4   4   
  Soft stool                0                    1                1                1                            1           
  Compound -colored stool   0                    0                0                0                            0           

NOA, No Observable Abnormality.

###### 

Summary of clinical signs 2 in rats exposed to red ginseng marc oil (RMO)

  Sex                      Group/ Dose (mg/kg)   No. of animals   Clinical signs   Days after dosing                                                       
  ------------------------ --------------------- ---------------- ---------------- ------------------- --- --- --- --- --- --- --- --- --- --- --- --- --- ---
  Male                     RMO 0                 5                NOA              5                   5   5   5   5   5   5   5   5   5   5   5   5   5   5
  RMO 5,000                5                     NOA              2                4                   5   5   5   5   5   5   5   5   5   5   5   5   5   
  Soft stool               2                     1                0                0                   0   0   0   0   0   0   0   0   0   0   0           
  Compound-colored stool   1                     0                0                0                   0   0   0   0   0   0   0   0   0   0   0           
  Female                   RMO 0                 5                NOA              5                   5   5   5   5   5   5   5   5   5   5   5   5   5   5
  RMO 5,000                5                     NOA              4                5                   5   5   5   5   5   5   5   5   5   5   5   5   5   
  Soft stool               1                     0                0                0                   0   0   0   0   0   0   0   0   0   0   0           
  Compound-colored stool   0                     0                0                0                   0   0   0   0   0   0   0   0   0   0   0           

NOA, No Observable Abnormality.

###### 

Summary of necropsy findings in rats exposed to red ginseng marc oil (RMO)

  Sex                     Male   Female       
  ----------------------- ------ -------- --- -------
  Dose (mg/kg)            0      5,000    0   5,000
  No. of animals          5      5        5   5
  Unremarkable findings   5      5        5   5
  No. of examined         5      5        5   5

External surface and all organs in body cavity were unremarkable.
